GE Capital HFS Provides Financing to Cianna Medical
Cianna Medical announced it secured a $10 million financing deal with GE Capital Healthcare Financial Services. The funds will be used to further product development efforts in the breast conservation therapy market, as well as expand the commercialization of the company’s SAVI breast brachytherapy applicator.
“Cianna Medical is the only company dedicated exclusively to breast conservation therapy, and I’m extremely proud of the tireless efforts our team has made over the past several years to reduce the burden that breast cancer treatment places on women and their families,” said Jill Anderson, president and CEO of Cianna Medical. “This funding acknowledges the strength of our company and positions us favorably for continued research, development and expansion of products that improve women’s quality of life, both in the U.S. and abroad.”
Cianna Medical is a medical device company that manufactures and markets the SAVI breast brachytherapy applicator for the delivery of radiation after lumpectomy surgery.